Clinical Trial Update: Proteinuria in Renal Transplant Patients Treated With Dapagliflozin [NA]

View source ↗

Summary

This clinical trial update reports the completion of a study evaluating proteinuria in renal transplant patients treated with the SGLT2 inhibitor dapagliflozin.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• FARXIGA (dapagliflozin)

Snippet

Sponsor: University Hospital, Montpellier | Conditions: Chronic Kidney Diseases | NA | Status: COMPLETED